Get Started

NKTR

NASD Nektar Therapeutics
Oct 23, 2026 · 12:25 PM ET DELAYED Market Open

$37.22 ↓ -1.43 (-3.70%) Trading Down from the previous close of $38.65, $0.94 below the day’s high of $38.16

YTD change
-11.97%
vs 20-day SMA
-14.74%
vs 200-day SMA
-42.78%

Price ranges

Previous day
$37.00 $38.80
open $38.01 close $38.65
+$0.64 (+1.68%)
Today
$36.67 $38.16
open $37.73 now $37.22
-$0.51 (-1.35%)
Past week
$35.61 $40.35
from $37.72 now $37.22
-$0.50 (-1.33%)
Past month
$35.61 $62.40
from $59.38 now $37.22
-$22.16 (-37.32%)
This year
$33.40 $109.00
from $42.28 now $37.22
-$5.06 (-11.97%)

Price & Performance

-52.61 (-57.65%) / 6M

$31.31$52.92$74.54$96.15Apr 23Jul 24Oct 22

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 97.8% away from all-time highs of $1,670.40
  • NKTR is down 12% since the beginning of the year
  • NKTR is down 42% over the past 12 months
  • NKTR is down 37% over the past 1 month
  • 21% of all NKTR investors are betting against NKTR

NKTR reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -39.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-1.23
Earnings momentum +40.6% Quarterly EPS growth
Quarterly change +40.6%

Valuation

P/E ratio N/A
Enterprise value $729.2M
Beta 1.32

Balance sheet & scale

IncomeN/A
Revenue$54.6M
Cash$684.3M
Debt$135.9K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.3B

Nektar Therapeutics is a biotechnology company, which engages in the discovery and development of novel therapies which selectively modulate the immune system to treat autoimmune disorders. It also focuses on immunology and unparalleled expertise in polymer chemistry to create one-of-a-kind, highly-selective medicines with optimal therapeutic benefit. The company was founded in 1990 and is headquartered in San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $447.28 +2.04%
MRNA Moderna, Inc. $202.63 -17.57%
RVMD Revolution Medicines, Inc. $187.69 -3.39%
ROIV Roivant Sciences Ltd. $37.45 +1.77%
BNTX BioNTech SE Sponsored ADR $89.67 -1.77%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.